104 related articles for article (PubMed ID: 11650152)
1. The ethical approach to phase I clinical trials in oncology.
Durry G; Dion S
Drugs Exp Clin Res; 1986; 12(1-2-3):21-2. PubMed ID: 11650152
[No Abstract] [Full Text] [Related]
2. The ethical approach to phase II clinical trials in oncology.
Dion S
Drugs Exp Clin Res; 1986; 12(1-2-3):41-2. PubMed ID: 11650153
[No Abstract] [Full Text] [Related]
3. Ethics and errors of clinical trials and the role and place of different types of trial: introduction.
Mathé G; Reizenstein P
Drugs Exp Clin Res; 1986; 12(1-2-3):1-9. PubMed ID: 11650151
[No Abstract] [Full Text] [Related]
4. The ethical approach to randomization in oncology.
Arpaillange P; Dion S
Drugs Exp Clin Res; 1986; 12(1-2-3):99-103. PubMed ID: 11650154
[No Abstract] [Full Text] [Related]
5. Some ethical issues associated with HIV vaccine trials.
Novick A
AIDS Public Policy J; 1988; 3(3):46-8. PubMed ID: 11650102
[No Abstract] [Full Text] [Related]
6. The use of placebos in randomized clinical trials.
Levine RJ; Schafer A
IRB; 1985; 7(2):1-6. PubMed ID: 11649622
[No Abstract] [Full Text] [Related]
7. Cohort-specific consent: an honest approach to phase 1 clinical cancer studies.
Freedman B
IRB; 1990; 12(1):5-7. PubMed ID: 11651972
[No Abstract] [Full Text] [Related]
8. The moral imperatives of medical research in human subjects.
Lieberman JA; Sloan J
J Calif Alliance Ment Ill; 1994; 5(1):40-2. PubMed ID: 11653319
[No Abstract] [Full Text] [Related]
9. The ethics of phase I pediatric oncology trials.
Ackerman TF
IRB; 1995; 17(1):1-5. PubMed ID: 11653060
[No Abstract] [Full Text] [Related]
10. Advantages and drawbacks of the Zelen design for randomized clinical trials.
Horwitz RI; Feinstein AR
J Clin Pharmacol New Drugs; 1980 Jul; 20(7):425-7. PubMed ID: 11658484
[No Abstract] [Full Text] [Related]
11. Ethics of drug experimentation.
Sgreccia E
Dolentium Hominum; 1987; 4(2nd Yr. 1):60-75. PubMed ID: 11653200
[No Abstract] [Full Text] [Related]
12. Estimating risks and benefits in AIDS vaccine and drug trials.
Kessel E
AIDS Public Policy J; 1990; 5(4):186-8. PubMed ID: 11650977
[No Abstract] [Full Text] [Related]
13. Dilemmas in the use of active control groups in clinical research.
Makuch RW; Johnson MF
IRB; 1989; 11(1):1-5. PubMed ID: 11659084
[No Abstract] [Full Text] [Related]
14. The clinical-trials bottleneck.
Russo F
Atl Mon; 1999 May; 283(5):30, 32, 34, 36. PubMed ID: 11657639
[No Abstract] [Full Text] [Related]
15. The patient-physician relationship in clinical trials: an ethical dilemma?
Hill TP
Mak Rounds Health Faith Ethics; 1996 Jun; 1(19):5-7. PubMed ID: 11654392
[No Abstract] [Full Text] [Related]
16. Data monitoring committees: the moral case for maximum feasible independence.
Walters L
Stat Med; 1993 Mar; 12(5-6):575-80. PubMed ID: 11659537
[No Abstract] [Full Text] [Related]
17. Placebo-controlled trials and the logic of clinical purpose.
Freedman B
IRB; 1990; 12(6):1-6. PubMed ID: 11651265
[No Abstract] [Full Text] [Related]
18. Ethical dilemmas with studies in less-developed countries: AIDS research trials.
Barry M
IRB; 1991; 13(4):8-9. PubMed ID: 11651483
[No Abstract] [Full Text] [Related]
19. The paradoxical case of payment as benefit to research subjects.
Macklin R
IRB; 1989; 11(6):1-3. PubMed ID: 11650284
[No Abstract] [Full Text] [Related]
20. Trial of AIDS drug in U.S. lags as too few participants enroll.
Boffey PM
N Y Times Web; 1987 Dec; ():A1, B12. PubMed ID: 11646594
[No Abstract] [Full Text] [Related]
[Next] [New Search]
